skip to Main Content

London England’s first-ever ketamine clinic is set to open

Londoners will soon be able to access ketamine at England’s first-ever ketamine clinic. The clinic, run by wake, is an important step in the right direction for England, the psychedelic industry and Awakn investors. Awakn is a publicly traded company on the over-the-counter market with the ticker symbol of AWKNF.

England’s alcohol problem

Most people are surprised to learn that over 602,000 people living in Britain are classified as addicted drinkers. More than 80% of these drug addicts do not receive treatment simply because alcoholism is not considered as debilitating as other drug addictions. Although some alcoholics do not desire treatment, many would gladly accept help. The problem is that most forms of therapy and medication have proven ineffective in the quest to treat alcoholism.

Enter the psychedelics. The breakthrough alcoholism treatment with ketamine helps prevent relapses and also reduces side effects caused by other drugs. Awakn’s PR team is quick to point out that 75% of those who successfully detox from alcohol in the short term end up drinking again within six months.

An inside look at the London Ketamine Clinic

The London Ketamine Clinic is hospital-like in that it is light in color, spacious and as clean as possible. Wake up patients to the clinic are given ketamine-based psychedelics to help overcome alcoholism. This development is a boon to the addiction industry as well as psychedelic investors who own shares of Awakn.

Awakn’s team provides psychiatric assistance with a combination of ketamine and counseling. Ketamine is supplied as an intramuscular fusion. This psychedelic suppresses the part of the brain responsible for addiction and depression. Deletion of this region controls mental functions, including addiction, depression and more. Although SSRIs have the potential to dampen this segment of the brain, the dampening is not as significant as that caused by ketamine.

Ketamine and other psychedelics are unique in that they have the potential to generate neuroplasticity that catalyzes the growth of synapses as well as nerve connections in the brain, creating the ability for the patient to behave differently. The hope is that using ketamine will help alcoholics and other drug addicts change their thought patterns to the point of overcoming addiction.

Awakn Ketamine Trials

Awakn’s ketamine-assisted psychotherapy trials show that neuroplasticity resulting from the substance reached a crescendo 24 hours after infusion. The results are similar to those of studies conducted by Dr Evgeny Krupitsky almost 30 years ago. It appears that the optimal treatment frequency is three to four sessions over 30 minutes in which ketamine is infused by a psychedelic therapist.

Currently, the Awakn team plans to deliver the ketamine treatments to patients over a three-week period and assess progress (or lack thereof) at that point. In comparison to other treatment modalities, the use of ketamine has a relatively short duration, generating positive results in just a few months.

Ketamine will likely expand beyond the UK

Although the ketamine therapy available at Awakn clinics in the UK is reserved for those who meet certain criteria, there is a good chance that the psychedelic will become mainstream in the months and years to come. It should be mentioned that British residents refer themselves to the Awakn Clinic. The clinic does not receive NHS funding. As long as the clinic helps wean addicts from alcohol and other substances, it should eventually help build the momentum needed for ketamine use in other countries outside of England.

Back To Top